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Abstract
Purpose: Most head and neck malignant neoplasias are diagnosed in advanced stages. 
Another threatening element to the patients’ survival chances and quality of life is the high risk 
of developing a second primary tumor (SPT). SPT significantly worsens prognosis, and for that 
reason patients must be monitored for early diagnosis. The main objective of this study was to 
analyze the occurrence of SPTs in patients with oral squamous cell carcinoma (OSCC) treated 
in Erasto Gaertner Hospital (EGH), Curitiba, PR, Brazil, in a period of 16 years. 
Methods: Design: retrospective study. The sample comprised patients with OSCC  who 
developed SPT between January 1990 and December 2005. Demographic and clinical data 
were recorded form the patients’ medical charts and analyzed with descriptive statistics.
Results: During this period, 34,637 patients were admitted at EGH. A total of 1,637 (4.4%) 
patients were diagnosed with OSCC, and 37 (2.7%) developed a SPT. Patients who developed 
SPT were 29 (78.4%) male and 8 (21.6%) female, with a median age of 58 years old. The 
most frequent anatomical SPT site was the mouth, oropharynx and oesophagus, with an overall 
survival of 27%. 
Conclusion:  Patients  treated  from  OSCC  must  be  carefully  monitored  because  of  the 
increased risk of SPT, especially when there is a continuous history of tobacco and alcohol 
consumption.
Key words: Second primary tumor; squamous cell carcinoma; oral cancer; head and neck 
neoplasia 
Resumo
Objetivo: A maioria das neoplasias malignas de cabeça e pescoço é diagnosticada em estágios 
avançados. O alto risco de desenvolver um segundo tumor primário (STP) diminui a taxa 
de sobrevida dos pacientes. STP piora significativamente o prognóstico e estudos sobre ele 
devem ser realizados para se descobrir seus fatores de risco e melhor forma de tratamento. O 
principal objetivo deste estudo foi analisar a ocorrência de STP em pacientes com carcinoma 
epidermóide bucal (CEB) tratados no Hospital Erasto Gaertner (HEG), Curitiba, PRP , Brasil, 
num período de 16 anos. 
Metodologia: Um estudo retrospectivo foi realizado a fim de revisar os pacientes com CEB que 
desenvolveram STP entre Janeiro de 1990 e Dezembro de 2005. Os dados demográficos e 
clínicos foram coletados através dos prontuários médicos dos pacientes e foram analisados 
por estatística descritiva.
Resultados: Neste período, 34.637 pacientes foram admitidos no HEG. Um total de 1637 
(4,4%) pacientes recebeu diagnóstico de CEB, dos quais 37 (2,7%) desenvolveram STP . Os 
pacientes que desenvolveram STP eram 29 (78,4%) homens e 8 (21,6%) mulheres, com 
média de idade de 58 anos. Os sítios anatômicos mais frequentes para o STP foram a boca, 
orofaringe e esôfago; a taxa de sobrevivência foi de 27%. 
Conclusão: Pacientes tratados de CEB devem ser examinados cuidadosamente e monitorados 
regularmente por causa do alto risco de desenvolver um STP , especialmente aqueles que 
mantêm os hábitos de tabagismo e etilismo.
Palavras-chave: Segundo tumor primário; carcinoma epidermóide; câncer bucal; neoplasia 
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Introduction
Second primary tumors (SPTs) have a significantly worse 
prognosis on patients with head and neck squamous cell 
carcinoma (HNSCC) (1). Usually they have a bad prognosis, 
because SPTs occur in important sites, such as the lungs or 
esophagus or in previously irradiated or operated areas (2). 
Nowadays, the leading cause of death amongst head and 
neck cancer patients is the development of a SPT (3,4). 
The interval between the initial disease and the SPT usually 
ranges from 2 to 4 years. Frequently, patients who develop 
SPTs are relatively young, presented a first tumor diagnosed 
in early stages at sites favourable to treatment, factors which, 
at the same time, increase the chance both of survival and 
SPT development (2).
The  “field  cancerization”  hypothesis  is  considered  the 
key model to explain the biological mechanism leading to 
second tumors (5,6). In a classical study, Slaughter et al. (6) 
described features of what they called “field cancerization” 
suggesting that oral and oropharyngeal cancer can develop 
precancerous  changes  in  multifocal  areas,  presenting 
abnormal tissue surrounding the lesion. They also suggested 
that both cancers consist of multiple, independent lesions 
that sometimes coalesce, and the presence of abnormal tissue 
explains SPT and local recurrence.
The main objective of the present study was to analyze the 
incidence of SPTs in patients with oral cancer admitted to 
the EGH, in the city of Curitiba, PR, in the South of Brazil, 
between January 1990 and December 2005.
Methods
The study protocol of this retrospective study was approved 
by the institutional review board according to Brazilian 
regulations and international recommendations. The sample 
comprised  patients  diagnosed  with  oral  squamou  cell 
carcinoma (OSCC) that developed SPT, between January 
1990 and December 2005, admitted at EGH, in Curitiba. 
The eligibility criteria for patients to be included in the 
present study were: confirmed histopathologic diagnosis 
of OSCC; development of a SPT; and primary tumor(s) 
treated  through  curative  protocols  –  including  patients 
who received palliative radiotherapy with radiation doses 
equivalent to those of curative radiotherapy. Tumors were 
classified according to staging system proposed by the 
UICC (International Union Against Cancer) and the AJCC 
(American Joint Committee on Cancer). Subjects were 
excluded if they did not conclude or receive any treatment, 
those treated in other institutions or patients who underwent 
only chemotherapy.
Demographic data was collected from patients’ medical 
records, such as: age, gender, risk factors (tobacco and 
alcohol), staging, topography, treatment and SPT survival. 
SPTs diagnose was performed following Warren and Gates 
classification (5), i.e., each neoplasia should present well-
defined characteristics of malignancy, be distinct, and the 
probability of one being a metastasis of the other must be 
excluded. Multiple neoplasia were classified as simultaneous 
(tumors diagnosed at the same time), synchronous (tumors 
discovered within 6 months of their first detection), and 
metachronous (tumors detected more than 6 months apart). 
Recurring tumors that appeared either in adjacent areas to 
surgical incision, or in areas that received radiation, or in 
lymph nodes located in the drainage area of the first tumor 
were not included in this study. 
Active lesions that appeared from 6 months after treatment 
at the same site or adjacent area to the index tumor were 
considered local recurrence. In contrast, residual lesions 
were considered those that persisted after treatment or, in 
case of surgical treatment, whereby tissue was compromised, 
those that reappeared within the surgical margins. Finally, 
patients’  medical  records  for  screened  for  presence  of 
regional  recurrence  (i.e.,  metastases  in  regional  lymph 
nodes) and distant metastases. Data were analyzed by using 
descriptive statistics.
Results
From the patients admitted at EGH, during the period from 
January of 1990 and December 2005, thirty-seven patients 
developed SPTs, 29 (78.4%) were male and 8 (21.6%) female. 
The mean age was 58 years-old, ranging from 43 to 86 years-
old. As for the risk factors, 31 patients (83.8%) were smokers 
and 4 (10.8%) non-smokers – for the other two (5.4%) this 
piece of information was not available. Furthermore, 23 
patients (62.2%) reported alcohol consumption.
Primary tumors sites are described in Table 1. Most of the 
patients were diagnosed in advanced stage (13.5% CSIII and 
35.1% CS IV), 8 patients (21.7%) were diagnosed in CS I 
and 11 (29.7%) in CS II.
Table 1. Anatomical distribution of the primary tumors in the 
oral cavity.
Site N %
Floor of the Mouth 16 43.2
Bucal Muccosa 01 2.7
Gingiva 03 8.1
Tongue 15 40.5
Hard Palate 01 2.7
Alveolar bone 01 2.7
Total 37 100.0
Concerning the treatment of the index tumor, 7 patients 
(18.9%) underwent exclusive surgery, 23 patients (62.2%) 
were treated combining radiotherapy and surgery, 6 (16.2%) 
received only radiotherapy, and one patient (2.7%) was 
treated through a combination of surgery, chemotherapy 
and radiotherapy.
The most frequent site for SPT was the oral cavity in 15 
cases (40.5%) (Table 2). The most common oral site for SPT 
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by the floor of the mouth (22.2%), dental alveolus (11.1%), 
hard palate (5.6%), retromolar (2.8%) and buccal mucosa 
(2.8%). 
constitute a paramount risk factor for the development of 
SPT.
The present study showed an average interval between 
diagnosis of first primary tumor and SPT of 65 months, 
demonstrating  the  necessity  of  long  follow-ups  with 
careful screening for new lesions. Indeed, authors suggest 
that patients may develop SPTs up to 48 months after the 
diagnosis of the first tumor (2).
Patients with HNSCC history have a greater chance of 
developing other malignancies due carcinogenic agents 
exposure  (11),  particularly  tobacco  and  alcohol  (12). 
SPTs account for about one third of head and neck cancer-
related  deaths,  and  25%  of  all  patients  followed  in  a   
10-year period will develop a SPT (13,14). Farshadpour et 
al. (15) have found greater positivity levels of the protein 
p53 in the adjacent tumor mucosa in patients suffering from 
HNSCC associated with tobacco and alcohol consumption 
when compared to those who were not exposed to risk 
factors. 
The  term  “field  cancerization”  was  first  suggested  by 
Slaughter et al. (6), who defend that certain characteristics 
in areas adjacent to tumors, may explain or indicate the 
development of both SPTs and local recurrences. Indeed, 
when index HNSCC is compared to SPT of the respiratory 
tract,  they  usually  present  identical  patterns  of  genetic 
alteration (5). Particularly in the head and neck region, the 
epithelium may present countless genetic alterations, with 
no histopathological evidences of dysplasia whatsoever. For 
instance, one may find certain genetic alterations both in 
resected tumors of HNSCC and in the resection margins 
even though these very same margins are histologically 
cancer free (16). The fact that certain genetic alterations 
remain in histologically benign areas even after a complete 
tumor resection can be a predictive sign of local flaw or 
incorrect resection. 
Vaamonde et al. (17) found that the oral cavity as most 
frequent  SPT  site,  similarly  to  the  present  study.  The 
most  frequent  SPT  sites  were  the  mouth,  oropharynx 
and  esophagus,  with  an  average  survival  rate  of  27%. 
The  oral  cavity  is  an  easily  accessed  site  for  direct 
visualization,  which  could  help  early  diagnosis  of  oral 
cancer. A comprehensive understanding of HNSCC SPT 
and metastasis occurrence must be made to improve patients’ 
prognosis and survival rates. Furthermore, the incidence and 
fatal course of SPT must be taken into account for patient   
surveillance.
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Table 2. Distribution of the localization of the second primary 
tumors.
Site N %
Oral cavity 15 40.5
Esophagus 06 16.2
Stomach 01 2.7
Hypopharynx 01 2.7
Larynx 03 8.1
Liver  01 2.7
Ear 01 2.7
Oropharynx 06 16.2
Parotid gland 01 2.7
Prostate 01 2.7
Lung 01 2.7
Total 37 100.0
Patients follow-up confirmed that 10 (27%) were alive and 
did not present any signs of disease; 5 (13.5%) were alive 
and still suffered from SPT; 16 (43.2%) had died because 
of the disease; 2 (5.4%) had died but the cause was not 
mentioned; and another 2 (5.4%) failed to attend follow-up 
or could not be located by the Department of Statistics and 
Medical Records of the EGH. The average interval between 
index tumor diagnosis and SPT was 65 months. Four cases 
had to be excluded because the patients failed to attend 
follow-up. 
Discussion
SPTs are a life threatening risk for patients diagnosed with 
HNSCC. They are often fatal, and develop in 10 to 40% of 
patients with HNSCC (7,8). Tumor topography, particularly 
larynx, hypopharynx, oropharynx, major salivary glands and 
nasopharynx, and age can be considered risk factors for SPTs 
development (9).
 The present study found a SPT incidence rate of 2.2% with 
low survival rates after diagnosis (43.2%). According to 
Rapport et al. (10), the risk of developing multiple tumors 
of the upper airways and digestive tract is ten fold high 
for those patients suffering from HNSCC in comparison 
to general population. Despite the advances made in the 
treatment of HNSCC, the incidence of SPT in past decades 
has not decreased (5). Similarly, little or no improve has been 
seen in survival rates, which remained at 50% for 5-year 
survival (2). Rennemo et al. (2) observed the impact of a 
SPT in 2,000 patients suffering from HNSCC over a 10-year 
period of time, and concluded that primary tumors located 
in  oral  cavity  and  larynx  diagnosed  at  earlier  stages 370  Rev. odonto ciênc. 2010;25(4):367-370
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